InsidersTradesSigma
申报总数
公司
▲ 买入（0 笔）
▼ 卖出（0 笔）
内部人交易记录
高级管理人员已披露买入
0
已披露卖出
0
尚无足够的、已确定 T+90 期限的买入信号来衡量交易记录。
信号历史
无可用的信号评分。
Explore the full record of transactions filed by Plinio Mark D., Directeur Commercial. Director active across 1 company, notably Evelo Biosciences, Inc.. Cumulatively, 3 reports have been published. History available since 31 January 2023. The latest transaction was disclosed on 31 January 2023 (Attribution). Regulator: SEC (Form 4). The full history is free.
Companies and markets linked to Plinio Mark D.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
申报3 总计
1,250 股@ US$0.888.3% 占其流量Common StockSEC:0001694665-23-000004:0
1,250 股@ €1.756218.0% 占其流量Common StockSEC:0001694665-22-000132:0
1,250 股@ €3.589850.0% 占其流量Common StockSEC:0001694665-22-000029:0
3 条申报中的 3 条
About Plinio Mark D.
Mark D. Plinio is the Chief Commercial Officer at Evelo Biosciences, Inc. He is responsible for the company's commercial strategy and sales development. His role is essential in maximizing market opportunities and supporting Evelo's growth.
